Searched for
HEATHER BRESCH
Netflix Fall 2023 Movie Line-up: See the complete listNetflix offers a sneak peek into its forthcoming Original movie selection for the fall of 2023. With a mix of genres from biopics to animat...- Biocon gets US FDA nod to launch insulin glargineThe product branded as Semglee has an identical amino acid sequence to Sanofi’s Lantus® and is approved for the same indications. This is t...
- USFDA pulls up Mylan for manufacturing violations at Andhra plantIn a warning letter issued to the company's CEO Heather Bresch, the US Food and Drug Administration (USFDA) said inspectors during May 27 t...
- A look at some inspiring and important women leading major corporationsThe corporate world will lose a prominent woman leader when Indra Nooyi steps down as CEO of PepsiCo in October, after a 24-year stint at t...
- USFDA okays Mylan, Biocon's biosimilar of cancer drug HerceptinOgivri is the first USFDA approved biosimilar to Herceptin and the first biosimilar from Mylan and Biocon's joint portfolio approved in the...
- Mylan plans generic EpiPen to quell outcry over $600 costMylan has attracted scrutiny for increasing the treatment’s price 400% in nine years — EpiPen cost $57 for a single pen when the drugmaker ...
- PepsiCo CEO Indra Nooyi in Fortune's powerful women in business listPepsiCo CEO Indra Nooyi is the sole Indian-origin executive in Fortune's list of 50 most powerful women in business.
- Mylan gets warning letter from USFDA for lapses at 3 unitsUSFDA has issued a warning letter to Mylan Laboratories for violation of current good manufacturing practice norms at its three plants in K...
- Piramal Enterprises likely to hive off its critical care businessThe key driver is the valuation and if it does not match expectations, the deal may not move quickly,” an industry source, who claimed know...
- US court finds Teva's Copaxone patent invalid again: Natco PharmaNatco Pharma, a city-based drug maker, today said the US Court of Appeals for Federal Court has again found one of the patents of Teva's Co...
- Kiran Mazumdar-Shaw ranked no. 2 in power list of UK-based Medicine MakerMazumdar-Shaw has been ranked number two on The Medicine Maker Power List of 2015, an annual list which is compiled by UK-based The Medicin...
- Mylan Inc to acquire Famy Care's certain business for $ 800 millionMumbai-based Famy Care is focused on female reproductive health care and is world leader in supplying a wide range of contraceptive pills.
- Mylan may buy contraceptive co Famy Care for Rs 3,000 croreMylan is said to have pipped private equity bids from Bain Capital and Advent to move closer to a deal. Hong Kong-based AIF Capital holds 1...
- 29 people with 'soft' college majors who became extremely successfulHere are 29 extremely successful people who prove that it's possible to climb the ladder without a bachelor's degree in business or science.
- Mylan launches breast cancer drug in IndiaDrug major Mylan Inc today said it has launched breast cancer drug Hertraz Herceptin in India.
- Biocon gets DCGI nod to market biosimilar trastuzumab in IndiaBiocon today said it has received approval from the Indian drug regulator to market its biosimilar trastuzumab developed jointly with Mylan.
- Biocon gets DCGI nod to market biosimilar trastuzumab in IndiaBiocon said it has received approval to market its biosimilar trastuzumab developed jointly with Mylan for treating breast cancer.
- Biocon Inks Pact with Mylan for generic insulinIn 2009, Mylan and Biocon had come together to develop five blockbuster biologic drugs in cancer and pain areas.
- Natco, Mylan to appeal against New York district court verdictThe decision by the US court covers several patents for the chemical composition of Copaxone, methods of using the product and processes fo...
Load More
